Agilon Health (NYSE:AGL – Get Free Report) and CareDx (NASDAQ:CDNA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.
Profitability
This table compares Agilon Health and CareDx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Agilon Health | -6.09% | -146.03% | -24.55% |
| CareDx | -2.01% | -2.65% | -1.96% |
Valuation and Earnings
This table compares Agilon Health and CareDx”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Agilon Health | $5.93 billion | 0.32 | -$391.35 million | ($21.56) | -5.23 |
| CareDx | $379.80 million | 3.56 | -$21.35 million | ($0.16) | -163.63 |
CareDx has lower revenue, but higher earnings than Agilon Health. CareDx is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and price targets for Agilon Health and CareDx, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Agilon Health | 2 | 8 | 5 | 0 | 2.20 |
| CareDx | 1 | 4 | 1 | 0 | 2.00 |
Agilon Health presently has a consensus target price of $58.73, indicating a potential downside of 47.93%. CareDx has a consensus target price of $25.00, indicating a potential downside of 4.51%. Given CareDx’s higher possible upside, analysts plainly believe CareDx is more favorable than Agilon Health.
Volatility and Risk
Agilon Health has a beta of 3, meaning that its share price is 200% more volatile than the S&P 500. Comparatively, CareDx has a beta of 2.49, meaning that its share price is 149% more volatile than the S&P 500.
Summary
CareDx beats Agilon Health on 7 of the 12 factors compared between the two stocks.
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
About CareDx
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
